Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
J Neuroophthalmol ; 36(4): 412-413, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27111091

RESUMO

A 21-year-old nonobese woman developed headaches and papilledema while excessively using 3 topical preparations of vitamin A. Neuroimaging studies were unremarkable and opening pressure on lumbar puncture was 300 mm H2O with normal cerebrospinal fluid composition. After discontinuation of the topical vitamin A preparations, the symptoms and signs of increased intracranial pressure resolved. The association of intracranial hypertension and topical vitamin A application has only been reported once previously.


Assuntos
Pressão Intracraniana/efeitos dos fármacos , Pseudotumor Cerebral/induzido quimicamente , Vitamina A/efeitos adversos , Administração Tópica , Feminino , Humanos , Papiledema/diagnóstico , Papiledema/etiologia , Pseudotumor Cerebral/complicações , Pseudotumor Cerebral/diagnóstico , Vitamina A/administração & dosagem , Vitaminas/administração & dosagem , Vitaminas/efeitos adversos , Adulto Jovem
2.
Neurosciences (Riyadh) ; 19(3): 178-82, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24983278

RESUMO

Despite developments in acute stroke therapies, stroke continues to be a leading cause of death and disability worldwide. One major limitation from intravenous thrombolysis with tissue plasminogen activator (t-PA) is patient`s arrival to the emergency room at a tertiary care hospital after the therapeutic time-window, which is generally 270 minutes. The problem is worse for people living in suburban areas where stroke expertise can be missing. Therefore, telestroke networks were developed at several sites where a stroke neurologist at a tertiary hospital participates through synchronous audio-video teleconference in confirming diagnosis of stroke, assessing risks and benefits of giving IV t-PA, and making the decision with the patient and emergency physician at the local hospital. In this article, we will review the experience of major telestroke networks in North America and Europe, and the evidence of its safety and cost-effectiveness. Telestroke complexity, with regard to practice, manpower, quality assurance, and legal issues will be discussed briefly.


Assuntos
Serviços Médicos de Emergência/métodos , Acidente Vascular Cerebral/tratamento farmacológico , Telemedicina/métodos , Terapia Trombolítica/métodos , Ativador de Plasminogênio Tecidual/uso terapêutico , Fibrinolíticos/uso terapêutico , Humanos , Arábia Saudita , Tempo para o Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA